•
Oct 24, 2020

Patterson Q2 2021 Earnings Report

Reported strong revenue growth and adjusted earnings driven by customer resilience and strategic execution.

Key Takeaways

Patterson Companies reported a 9.5% increase in net sales to $1.55 billion and adjusted earnings per diluted share of $0.63, a 62% increase year-over-year, reflecting strong sales execution and expense discipline.

Net sales increased 9.5 percent year-over-year to $1.55 billion, with internal sales up 9.0 percent.

Adjusted operating margin increased by 130 bps to 5.3 percent.

Dental segment internal sales increased 12.1 percent due to strong growth in consumables, equipment, and services.

Animal Health segment internal sales increased 6.9 percent driven by Companion Animal performance and growth in the Production Animal business.

Total Revenue
$1.55B
Previous year: $1.42B
+9.4%
EPS
$0.63
Previous year: $0.39
+61.5%
Adjusted Operating Margin
5.3%
Previous year: 4%
+32.5%
Gross Profit
$320M
Previous year: $301M
+6.3%
Cash and Equivalents
$139M
Previous year: $130M
+7.6%
Free Cash Flow
-$201M
Previous year: $16.6M
-1310.1%
Total Assets
$2.79B
Previous year: $3.44B
-18.8%

Patterson

Patterson

Patterson Revenue by Segment

Forward Guidance

Due to the continued uncertainty surrounding the COVID-19 pandemic and its impact on business operations, Patterson is not providing fiscal 2021 financial guidance at this time.

Revenue & Expenses

Visualization of income flow from segment revenue to net income